Know how to monitor patients for hepatotoxic drug effects
Level
This learning outcome is a primary level outcome.
Sessions
This learning outcome is taught in the following sessions:
-
Gastroenterology and Cancer (MET3A) (Year 3)
- SDL & CE: Pharmacological Management of Liver Disease (Priority 3)
Assessment
This learning outcome is assessed in the following ways:
- NOT YET CATEGORISED
